Voya Financial offers enhanced critical illness insurance, spurred by the pandemic
Voya Financial has enhanced its critical illness insurance to aid employees affected by severe infectious diseases like COVID-19. This new Infectious Condition Additional Benefit Rider offers flexibility and additional benefits, responding to rising employee concerns over medical costs. Research indicates nearly half of Americans are reconsidering workplace benefits due to the pandemic, prompting employers to explore additional voluntary coverage options. The Rider can complement existing policies, helping tackle evolving health and financial needs, which may also aid in employee recruitment and retention.
- Introduction of the Infectious Condition Additional Benefit Rider enhances critical illness insurance coverage.
- Responds to increased employer interest in voluntary benefits, with 22% of employers considering critical illness insurance.
- Supports employee recruitment and retention by offering more comprehensive benefits, appealing to 74% of workers who prefer employers providing voluntary benefits.
- None.
New optional rider offers flexibility and additive benefits to help employees diagnosed and/or hospitalized from a severe infectious disease, like COVID-19
With Voya’s research showing that nearly half of Americans (
Voya’s critical illness insurance pays a lump-sum benefit upon the diagnosis of a covered illness or condition, such as a heart attack, cancer or stroke. This benefit can be used for out-of-pocket medical costs, as well as household expenses like rent, utilities or a mortgage. Since the onset of the global pandemic, COVID-19 has been covered under the Infectious Disease Benefit option in our critical illness insurance. That option pays a percentage of the critical illness benefit amount, if the insured is diagnosed with an infectious disease that results in a hospital stay for a specified number of consecutive days.
Now, Voya is offering employers the ability to include an Infectious Condition Additional Benefit Rider (“Rider”) as well. Using a COVID-19 diagnosis, here’s how the new Rider could complement the existing Infectious Disease Benefit, if employers include both with their critical illness insurance.4 This example also includes the optional Wellness Benefit, which provides an annual benefit for a completed health screening test.
- Covered employee, John, completes a COVID-19 test administered by a medical professional. Regardless of the results, and because he has not yet used it, he is eligible for his annual Wellness Benefit. Under the new Rider, when John is diagnosed with COVID-19, he is now eligible for the Diagnosis Benefit. When the diagnosis results in a hospitalization of at least 20 consecutive hours in an observation unit, or confined as a resident inpatient, he then becomes eligible for the Hospital Confinement Benefit. If his hospital stay lasts for five or more consecutive days based on his diagnosis, John would then be eligible for the Infectious Disease Benefit.
-
Sample benefit amounts for this example are as follows5:
-
Wellness Benefit:
$50 -
New Rider – Infectious Condition Diagnosis Benefit:
$100 -
New Rider – Infectious Condition Hospital Confinement Benefit:
$1,000 -
Infectious Disease Benefit –
25% of John’s maximum critical illness insurance benefit amount of ,000:$10 $2,500
-
Wellness Benefit:
“A person’s road to recovery from an infectious disease is not a one-size-fits-all experience. Even if an individual is diagnosed and needs to go to the hospital for a relatively short period of time, it can be difficult and there is likely a financial impact,” explained
Given the interest by employers in offering critical illness insurance to their employees, this new Rider offers additional features and flexibility. For example, employers can initially choose whether to offer this Rider to their employees, and then determine coverage amounts, which components to include (diagnosis and/or hospital confinement) and tailor their list of covered infectious diseases.
“Not only can this new Rider help address the evolving health and financial needs of employees, but it’s also another way to help address recruiting and retention needs. A recent Voya survey found that three quarters of working Americans (
Voya’s supplemental insurance solutions — including our new Rider available with critical illness insurance — are offered through the workplace as voluntary or employee-selected coverage that are processed and administered similarly to traditional group insurance. Employers may choose to: fund the plan for their employees; offer it as an option employees can purchase through their workplace benefits; or create a combined option in which the employer pays a portion of the benefit and the employee can purchase additional coverage.
As an industry leader focused on the delivery of health, wealth and investment solutions to and through the workplace,
1) Based on the results of a
2) MarketVision™ – The Employer Viewpoint© 2020,
3) MarketVision™ – The Employee Viewpoint© 2021,
4) The Infectious Disease Benefit is available as an option under the “Quality of Life” module in the Critical Illness Policy. The Infectious Disease Benefit and the Infectious Condition Additional Benefit Rider are both available to be included in an employer’s coverage and are also available individually. Provisions and availability may vary by state. The Infectious Condition Additional Benefit Rider is not available in
5) This is provided as an example only and assumes
About
Insurance products are issued by
VOYA-EB
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005122/en/
Media Contact:
Cell: (315) 373-9685
William.Sutton@voya.com
Source:
FAQ
What is the new benefit introduced by Voya Financial for COVID-19?
How does the new Voya rider impact employee health benefits?
What percentage of US employers currently offer critical illness insurance?
How does the new rider align with employee interests?